OSE Pharma SA (OSE) - Total Liabilities

Latest as of June 2025: €53.58 Million EUR ≈ $62.64 Million USD

Based on the latest financial reports, OSE Pharma SA (OSE) has total liabilities worth €53.58 Million EUR (≈ $62.64 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore OSE cash flow metrics to assess how effectively this company generates cash.

OSE Pharma SA - Total Liabilities Trend (2012–2024)

This chart illustrates how OSE Pharma SA's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are OSE Pharma SA's assets to evaluate the company's liquid asset resilience ratio.

OSE Pharma SA Competitors by Total Liabilities

The table below lists competitors of OSE Pharma SA ranked by their total liabilities.

Company	Country	Total Liabilities
Peel Mining Ltd AU:PEX	Australia	AU$1.76 Million
Anfield Energy Inc. NASDAQ:AEC	USA	$37.29 Million
M&G Plc LSE:MNG	UK	GBX187.41 Billion
Full House Resorts Inc NASDAQ:FLL	USA	$66.87 Million
Aminologics Co.Ltd KQ:074430	Korea	₩26.95 Billion
Embellence Group AB ST:EMBELL	Sweden	Skr278.00 Million
Reworld Media PA:ALREW	France	€375.91 Million
Brand X Co. Ltd. KQ:337930	Korea	₩64.82 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down OSE Pharma SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see OSE stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.87	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.74	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.51	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how OSE Pharma SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for OSE Pharma SA (2012–2024)

The table below shows the annual total liabilities of OSE Pharma SA from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	€60.15 Million ≈ $70.32 Million	+1.81%
2023-12-31	€59.08 Million ≈ $69.07 Million	-0.07%
2022-12-31	€59.12 Million ≈ $69.12 Million	+9.52%
2021-12-31	€53.99 Million ≈ $63.12 Million	+51.61%
2020-12-31	€35.61 Million ≈ $41.63 Million	+17.15%
2019-12-31	€30.40 Million ≈ $35.54 Million	+100.65%
2018-12-31	€15.15 Million ≈ $17.71 Million	-30.85%
2017-12-31	€21.91 Million ≈ $25.61 Million	-12.45%
2016-12-31	€25.02 Million ≈ $29.25 Million	+893.33%
2015-12-31	€2.52 Million ≈ $2.94 Million	-9.49%
2014-12-31	€2.78 Million ≈ $3.25 Million	+131.92%
2013-12-31	€1.20 Million ≈ $1.40 Million	+31.15%
2012-12-31	€915.00K ≈ $1.07 Million	--

About OSE Pharma SA

PA:OSE France Biotechnology

Market Cap

$100.23 Million

€85.73 Million EUR

Market Cap Rank

#19647 Global

#299 in France

Share Price

€3.82

Change (1 day)

-3.29%

52-Week Range

€3.02 - €7.20

All Time High

€15.00